• TargetScan Touch
  • Targeted Biopsy System
  • TargetScan Technology
  • TargetScan Advantages
  • TargetScan Touch Simulator
•    |   
• Professionals
  • Clinical Data
  • TargetScan Specifications
  • TargetScan Literature
•    |   
• Patients
  • Detection
    • Prostate Ultrasound
    • TRUS Ultrasound
    • Benign Prostatic Hyperplasia
    • Prostate Specific Antigen
  • Treatments
    • Brachytherapy
    • Cryotherapy
    • HIFU
    • HDR
  • Patient Experiences
•    |   
• About Prostate Cancer
  • Prostate Cancer Stages
  • Prostate Cancer Biopsy
  • Prostate Cancer Prevention

Prostate Cancer & Risks

Prostate cancer stems from malignant tumor that begins growing in the prostate gland. As the malignant tumor grows, It can spread from the prostate to other areas of the body, including nearby lymph nodes, bones, or other organs. Prostate cancer is the second leading cause of cancer death in men. The good news is that survival rates have improved a great deal. In the past 20 years, 5-year survival rates for all stages of prostate cancer combined have increased from 67% to 99% due to advances in medical technology and detection equipment.

While researchers still do not know exactly what causes prostate cancer, they have identified some risk factors. As men age, the risk of developing prostate cancer increases. More than 70% of all prostate cancers are diagnosed in men over age 65. Family history also plays into the increased risk of prostate cancer. For example, men whose father and/or brother have been diagnosed with prostate cancer are up to 11 times more likely to develop prostate cancer. Additionally, research shows that the prostate cancer death rate in African-American men is almost 2.4 times higher than in Caucasian men, which is why early screening in African-American is recommended.

Additionally, research suggests that diet can affect prostate health. It is important not only in regards to prostate cancer, but also overall well being, that a proper diet is executed to keep the body healthy. Research has shown that the death rate from prostate cancer increase in obese men.

Envisioneering Medical focuses resources and technology to develop equipment to aid physicians in detection, diagnosis and treatment. The TargetScan 3D imaging and targeted biopsy system offers the first real advance in prostate imaging and biopsy in over a decade. It eases any discomfort of probing during examination, as once it is place, there is no need for repositioning. The system allows a physician to generate a true solid 3D image, manipulate it, and precisely plan and undertake a multi-sample biopsy of a targeted tissue mass in the prostate. Click to learn more about TargetScan 3D or ask your physician today.